News / Taiwan / economic_daily
ABC-KY Reports 70% Revenue Growth Driven by US Respiratory Testing Demand
Health Technology · Biotechnology · economic_daily · 2026-10-07
6598
ABC-KY announced a 70% year-over-year revenue increase for the first three quarters, fueled by surging demand for respiratory testing in the North American market.
What Happened
Financial Performance: ABC-KY reported cumulative revenue of NT$610 million for the first three quarters, marking a significant year-over-year increase of over 70%. Analysts expect this growth momentum to continue as seasonal testing demand rises and new client acquisitions contribute to the company's top line.
Market Demand: The North American market is seeing a surge in respiratory testing demand as the flu season approaches. Furthermore, major laboratory clients are consolidating testing services from regional labs and long-term care facilities, driving increased utilization of ABC-KY's high-throughput, automated diagnostic solutions.
Product Development: The company's core 'Digital Biological Barcode' platform has secured FDA approval and is currently used by several national laboratories in the US. ABC-KY is actively developing an advanced respiratory panel that integrates COVID-19 testing to offer one of the most comprehensive diagnostic solutions on the market.
Strategic Positioning: ABC-KY maintains a unique dual-market strategy, serving both the human in-vitro diagnostics sector and the animal health market through a partnership with IDEXX. By leveraging its automated BioCode MDx-3000 system, the company continues to expand its footprint in the competitive US diagnostic landscape.